Bioxcel therapeutics to present bxcl701 clinical data at the society for immunotherapy of cancer's 35th anniversary annual meeting

Encouraging signals of activity in difficult-to-treat tumors observed in both ongoing trials with bxcl701 and pembrolizumab (keytruda®)

BTAI Ratings Summary

BTAI Quant Ranking